This is the authors' abstract. We don't add key points for this paper.
The clinical behavior and molecular characteristics of alveolar cases without a fusion gene are indistinguishable from embryonal cases and significantly different from fusion-positive alveolar cases. This implies that fusion gene status irrespective of histology is a critical factor in risk stratification of RMS.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Williamson et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: